Use of Clozapine in Canada

There is consistent and abundant evidence that clozapine is effective in treatment-resistant schizophrenia compared to all other first or second generation antipsychotic agents.

The Canadian Consortium for Early Intervention in Psychosis will be evaluating the profile of clozapine use within the first two years of diagnosis of non-affective psychosis.

  • Project Lead: Dr. Richard Williams
  • Project Sponsor: Mylan Pharmaceuticals
filed under: